| abstract |
Group consisting of bendamustine or a pharmaceutically acceptable ester, salt or solvate thereof, and polyethoxylated castor oil or derivatives thereof and block copolymers of ethylene oxide and propylene oxide as active ingredients in the present invention An oral pharmaceutical composition is provided comprising a pharmaceutically acceptable excipient which is a pharmaceutically acceptable non-ionic surfactant selected from. |